Evidence by cancer type
Metronomic therapy in lung cancer
167 studies and 34 trials indexed. 5 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 4ChinaNCT07744698Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)Anhui Provincial Cancer Hospital
- RecruitingPhase 2FranceNCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerGustave Roussy, Cancer Campus, Grand Paris
- RecruitingPhase 2RussiaNCT07130032Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeEuroCityClinic LLC
- RecruitingNot statedChinaNCT07041320Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung CancerAnhui Chest Hospital
- Not yet recruitingPhase 2NCT07698054Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung CancerHenan Cancer Hospital
See all 34 trials for lung cancer in the trial finder
Newest studies
- StudyNeoplasma2026 OctAfatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.Yin C, et al.
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- StudyBMC Cancer2026 Jul 17Efficacy and safety of metronomic oral vinorelbine in elderly patients with locally advanced and metastatic non-small cell lung cancer.Soliman SH and Atef MM
- StudyCells2026 Jun 29IVMT-Rx-3 Microemulsion as Low-Dose Metronomic Chemotherapy for Melanoma Metastasis.Pangeni R, et al.
- ReviewTransl Cancer Res2026 Apr 30Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review.Li S, et al.
- Clinical trialNat Commun2026 Apr 10Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study.Cives M, et al.
- StudyAnticancer Res2025 DecInhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus.Amano Y, et al.
- StudyMolecules2025 Sep 12Synthesis, Clastogenic and Cytotoxic Potential, and In Vivo Antitumor Activity of a Novel N-Mustard Based on Indole-3-carboxylic Acid Derivative.Filimonova M, et al.
- StudyAnticancer Drugs2025 Aug 1Efficacy of immune checkpoint inhibitors rechallenge and metronomic cyclophosphamide with or without bevacizumab in metastatic nonsmall cell lung cancer.Musaelyan AA, et al.
- Clinical trialPediatr Blood Cancer2025 JulResults of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval-Compressed Multiagent and Metronomic Chemotherapy.Rose A, et al.
- StudyInt J Clin Oncol2025 JunCorrection: The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.Xu K, et al.
- StudybioRxiv2025 May 6Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.Pedroza DA, et al.
- Randomized trialJ Chemother2025 AprCombination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial.Azim HA, et al.
- StudyClin Transl Oncol2024 DecEfficacy and safety of metronomic oral vinorelbine and its combination therapy as second- and later-line regimens for advanced non-small-cell lung cancer: a retrospective analysis.Chen S, et al.
- ReviewMol Cancer2024 Oct 31Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.Kesharwani P, et al.
- StudyWorld J Clin Oncol2024 Jul 24Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway.Cai Z, et al.
- Clinical trialESMO Open2024 MayA new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial.von Arx C, et al.
- Case reportHeliyon2024 Jan 30An epidermal growth factor receptor-mutated lung adenocarcinoma patient with brain lesions resisted to osimertinib monotherapy but achieved more than 4 years of survival in osimertinib plus bevacizumab metronomic treatment.Liu J, et al.
- ReviewCancers (Basel)2023 Dec 29Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.Harrer DC, et al.
- Case reportFront Oncol2023(125)I Radiotherapy combined with metronomic chemotherapy may boost the abscopal effect, leading to complete regression of liver metastasis in an SCLC patient with a 58.5-month OS: a case report.Lu L, et al.
- Clinical trialLung Cancer2023 AprSafety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).Vergnenegre A, et al.
- StudyAnticancer Agents Med Chem2023Efficacy of Osimertinib Continuation Plus Metronomic Oral Vinorelbine for EGFRmutant Advanced NSCLC Beyond Limited Progression on Osimertinib.Li M, et al.
- StudyCancers (Basel)2022 Dec 9Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial.Camerini A, et al.
- StudyNeuro Endocrinol Lett2022 Sep 16A retrospective observational study on cases of osteosarcomas treated with a multitherapy: The rationale and effectiveness.Di Bella G, et al.
- StudyPulmonology2022 Sep-OctMetronomic oral vinorelbine in a real-world population of advanced non-small cell lung cancer patients.Estevinho F, et al.
- Clinical trialCancer Chemother Pharmacol2022 AugRevisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer.Barlesi F, et al.
- StudyFront Oncol2022Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults.Bodea J, et al.
- Case reportMonaldi Arch Chest Dis2022 Apr 1Two years progression-free survival under vinorelbine metronomic therapy of a patient with metastatic epithelioid hemangioendothelioma.Anevlavis S, et al.
- Case reportAnn Med Surg (Lond)2021 DecMetronomic chemotherapy with cyclophosphamide for the treatment of advanced hepatocellular cancer: A case report.Peristeri DV, et al.
- StudyFront Immunol2021MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response.Tagliamonte M, et al.
- StudyBiomed Microdevices2021 Oct 1A novel design of microfluidic platform for metronomic combinatorial chemotherapy drug screening based on 3D tumor spheroid model.Sankar S, et al.
- StudyTransl Lung Cancer Res2021 JulRandomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Zhang M, et al.
- StudyCancers (Basel)2021 May 7Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer.Bondarenko M, et al.
- ReviewCancers (Basel)2021 May 6Metronomic Chemotherapy.Cazzaniga ME, et al.
- StudyJ Chemother2021 MayActive metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma.Orlandi P, et al.
- StudyCancers (Basel)2021 Apr 15Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC.Skavatsou E, et al.
- Randomized trialESMO Open2021 AprMetronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.Camerini A, et al.
- StudyFront Pharmacol2021A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).Heudobler D, et al.
- Case reportCase Rep Oncol2021 Jan-AprRefractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab.Cardona AF, et al.
- Clinical trialLung Cancer2021 MarPhase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection.Provencio M, et al.
